Potassium Phosphates (Potassium Phosphates)

**Product type:** Human Prescription Drug

**Active ingredient:** DIBASIC POTASSIUM PHOSPHATE; MONOBASIC POTASSIUM PHOSPHATE

**Strength:** 236; 224 mg/mL; mg/mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** Cipla USA Inc.

**Marketing category:** ANDA (ANDA217892)

**Pharmacologic class:** Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]